Brief: Oncopeptides Completes Directed Share Issue Of SEK 100 Mln
14/10/2026 06:40
BRIEF-Oncopeptides Completes Directed Share Issue Of SEK 100 Mln Oct 14 (Reuters) - Oncopeptides AB ONCO.ST:
SAID ON TUESDAY HAD RESOLVED ON DIRECTED SHARE ISSUE OF 50,000,000 NEW ORDINARY SHARES AT SUBSCRIPTION PRICE OF SEK 2.00 PER SHARE
WILL RECEIVE PROCEEDS OF SEK 100 MILLION BEFORE DEDUCTION OF TRANSACTION COSTS
SUBSCRIPTION PRICE CORRESPONDS TO DISCOUNT OF ABOUT 13.9% TO CLOSING PRICE OF SEK 2.324 FOR ONCOPEPTIDES SHARE ON NASDAQ STOCKHOLM ON OCTOBER13
TO USE NET PROCEEDS TO CARRY OUT THE CMC ACTIVITIES REQUIRED AHEAD OF NEXT CLINICAL DEVELOPMENT PHASE, AND FINANCE EXECUTION WITHIN GLIOBLASTOMA PROGRAMME
Source text for Workspace: nMFN4zfqLr
Further company coverage: ONCO.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Oncopeptides AB
See all newsSweden's Oncopeptides Q3 net sales rise on Pepaxti demand
Brief: Oncopeptides Q3 Operating Profit SEK -36.47 Million
Brief: Oncopeptides Completes Directed Share Issue Of SEK 100 Mln
Brief: Oncopeptides Confirms Blood-Brain-Barrier Penetration In Glioblastoma Study
Swedish biotech Oncopeptides' Q2 net sales rise on strong demand in Italy